Webinar: Our experts discuss NICE's proportionate approach to technology appraisals and the implicat...
Read moreThis research aims to understand if just three PICOs are feasible by analysing recent HTA assessment...
Read moreOur research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in...
Read moreOur study aims to understand how the severity modifier has been implemented so far and its impact on...
Read moreWe outline the challenges pharma companies encounter when launching cell and gene therapies, and ass...
Read moreGermany is reshaping its Ministry of Health to prioritize the prevention of diseases like cancer, de...
Read moreWebinar: Our experts discuss Orphan medicine market access in Europe including the impact of EU HTA ...
Read moreThis article explores the significant disparities between the US and Europe regarding orphan drugs a...
Read moreMEAs resulted in 195.2 million of savings for the Italian healthcare system, according to AIFA’s M...
Read moreWe explore the innovative assessment criteria for novel cancer therapies and the unmet needs in onco...
Read more